We help you to identify, qualify, and prioritize possible in- and out-licensing evaluation candidates and evaluate their commercial potential. With substantial capabilities including rapid assessment and comprehensive due diligence, we can provide information and guidance across each phase of your engagement.
Our clinical, epidemiology, access, and forecasting experts work collaboratively to support holistic and comprehensive in- and out-licensing evaluations, ensuring confident decision-making.
We can support you as part of a long-term strategic process or as tactical support at critical points that may require an independent validation.
We draw upon data sources such as the Oracle Life Sciences Epi Database, Oracle Life Sciences CancerMPact, and Oracle EHR Real-World Data, plus vital medical literature, government databases, and patient surveys. Our experts can deliver accurate, holistic insights into market trends to inform your decisions regarding in- and out-licensing opportunities.
Our experts work across disciplines to support your decision-making around licensing options, enabling you to
Habla con un miembro del equipo sobre las soluciones de Oracle para ciencias biológicas.
Escucha a científicos, médicos y líderes de la industria farmacéutica, biotecnológica y organizaciones de investigación clínica, que están impulsando la innovación en las ciencias biológicas y la salud.
Consulta los contactos y recursos de asistencia técnica.